Dextrorphan
From Wikipedia, the free encyclopedia
Dextrorphan (DXO) is a pharmacologically active metabolite of dextromethorphan (DXM).
Dextrorphan
|
|
Systematic (IUPAC) name | |
17-methyl-9a,13a,14a-morphinan-3-ol | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C17H23NO |
Mol. mass | 257.371 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Contents |
[edit] Chemistry
It is the result of O-demethylation of the prodrug by several enzymatic systems, although it is chiefly a product of the Cytochrome P450 IID6 (CYP2D6) pathway.
[edit] Pharmacology
Dextrorphan is structurally similar to dextromethorphan, and has an affinity for the same receptors in the central nervous system, although with a slight difference in selectivity. While dextromethorphan is a weak non-competitive NMDA receptor antagonist, dextrorphan is a more potent antagonist[1].
It should be noted, however, that due to its potency as an NMDA receptor antagonist, as well as the fact that it is produced as a by-product of DXM metabolization in the body, DXO is thought to be largely responsible for the psychological side-effects that occur at high doses of DXM. These side-effects can include alteration of consciousness, or "cognitive dissociation", which are characteristic of NMDA blockade and which have afforded DXM its potential for use as a recreational drug.
[edit] See also
- Levorphanol
- Dextromethorphan
- Ketamine (compound that acts most similarly to dextrorphan)
- Hallucinogen
- Psychedelic
- Racemethorphan
- Morphinans